搜索表单

您现在的位置:首页  > 新闻聚焦 > 通知公告

专题

细胞治疗速递 更多>>

  • 细胞治疗速递

    2016年12月(总第27期)

  • 细胞治疗速递

    2016年11月(总第26期)

讲座-预告丨实体瘤免疫治疗新进展——制药巨头Celgene副总裁Stefan Gluck教授

stdClass Object ( [vid] => 1489 [uid] => 1024 [title] => 讲座-预告丨实体瘤免疫治疗新进展——制药巨头Celgene副总裁Stefan Gluck教授 [log] => [status] => 1 [comment] => 1 [promote] => 0 [sticky] => 0 [nid] => 1489 [type] => article [language] => zh-hans [created] => 1490259556 [changed] => 1492997613 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1492997613 [revision_uid] => 1024 [body] => Array ( [und] => Array ( [0] => Array ( [value] => 2017年03月26日(本周日)上午10:00美国制药巨头Celgene公司副总裁、肿瘤学大牛Stefan Gluck教授来中心做关于《实体瘤免疫治疗新进展》学术讲座。欢迎广大对肿瘤免疫治疗研究有着深厚热情的学者们共同参与。 03月26日 周日 讲座题目:Immunotherapy in Solid Tumors: New Developments 讲座嘉宾:Stefan Gluck教授 讲座时间:3月26日 10:00-10:30 讲座地点:上海细胞治疗集团多功能室(嘉定区安亭镇前杨路75号A座) 报名方式:叶博士:13661913449 Celgene 塞尔基因 Celgene(新基生物制药)创立于1980年,是一家以生物制药为主的全球企业。美国500强企业,是美国十大生物科技企业之一。 Celgene近几年将主要研发目标聚焦于肿瘤免疫治疗,已成功研发多个免疫治疗药物。 Celgene公司最近先后披露了包括CAR-T疗法在内的多个合作研发协议,这些研发协议涉及了Juno公司、BlueBird公司以及Jounce公司和阿斯利康公司。这一系列大动作让人确信Celgene公司将会在肿瘤免疫疗法领域大干一场。 Dr. Stefan Gluck MD Dr. Stefan Gluck is a medical oncologist in Summit, New Jersey and is affiliated with multiple hospitals in the area, including Jackson Memorial Hospital and University of Miami Hospital. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice for more than 20 years. He is one of 24 doctors at Jackson Memorial Hospital and one of 31 at University of Miami Hospital who specialize in Medical Oncology. He also speaks multiple languages, including German. [summary] => [format] => full_html [safe_value] => 2017年03月26日(本周日)上午10:00美国制药巨头Celgene公司副总裁、肿瘤学大牛Stefan Gluck教授来中心做关于《实体瘤免疫治疗新进展》学术讲座。欢迎广大对肿瘤免疫治疗研究有着深厚热情的学者们共同参与。 03月26日 周日 讲座题目:Immunotherapy in Solid Tumors: New Developments 讲座嘉宾:Stefan Gluck教授 讲座时间:3月26日 10:00-10:30 讲座地点:上海细胞治疗集团多功能室(嘉定区安亭镇前杨路75号A座) 报名方式:叶博士:13661913449 Celgene 塞尔基因 Celgene(新基生物制药)创立于1980年,是一家以生物制药为主的全球企业。美国500强企业,是美国十大生物科技企业之一。 Celgene近几年将主要研发目标聚焦于肿瘤免疫治疗,已成功研发多个免疫治疗药物。 Celgene公司最近先后披露了包括CAR-T疗法在内的多个合作研发协议,这些研发协议涉及了Juno公司、BlueBird公司以及Jounce公司和阿斯利康公司。这一系列大动作让人确信Celgene公司将会在肿瘤免疫疗法领域大干一场。 Dr. Stefan Gluck MD Dr. Stefan Gluck is a medical oncologist in Summit, New Jersey and is affiliated with multiple hospitals in the area, including Jackson Memorial Hospital and University of Miami Hospital. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice for more than 20 years. He is one of 24 doctors at Jackson Memorial Hospital and one of 31 at University of Miami Hospital who specialize in Medical Oncology. He also speaks multiple languages, including German. [safe_summary] => ) ) ) [field_tags] => Array ( [und] => Array ( [0] => Array ( [tid] => 72 ) [1] => Array ( [tid] => 54 ) [2] => Array ( [tid] => 60 ) ) ) [field_image] => Array ( ) [field_titleimage] => Array ( [und] => Array ( [0] => Array ( [fid] => 43 [uid] => 1 [filename] => news_file.png [uri] => public://default_images/news_file.png [filemime] => image/png [filesize] => 145136 [status] => 1 [timestamp] => 1428861916 [origname] => news_file.png [rdf_mapping] => Array ( ) [is_default] => 1 [alt] => [title] => ) ) ) [field_attach] => Array ( ) [field_display_index] => Array ( [und] => Array ( [0] => Array ( [value] => 0 ) ) ) [rdf_mapping] => Array ( [field_image] => Array ( [predicates] => Array ( [0] => og:image [1] => rdfs:seeAlso ) [type] => rel ) [field_tags] => Array ( [predicates] => Array ( [0] => dc:subject ) [type] => rel ) [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1490259556 [last_comment_name] => [last_comment_uid] => 1024 [comment_count] => 0 [domains] => Array ( [4] => 4 [7] => 7 [9] => 9 ) [domain_site] => 1 [subdomains] => Array ( [0] => All affiliates [1] => 管理后台 [2] => shcell.com - 细胞中心 [3] => 上海细胞治疗研究院 ) [name] => zhangwanting [picture] => 0 [data] => a:6:{s:16:"ckeditor_default";s:1:"t";s:20:"ckeditor_show_toggle";s:1:"t";s:14:"ckeditor_width";s:4:"100%";s:13:"ckeditor_lang";s:2:"en";s:18:"ckeditor_auto_lang";s:1:"t";s:7:"overlay";i:1;} [entity_view_prepared] => 1 )
2017年03月26日(本周日)上午10:00美国制药巨头Celgene公司副总裁、肿瘤学大牛Stefan Gluck教授来中心做关于《实体瘤免疫治疗新进展》学术讲座。欢迎广大对肿瘤免疫治疗研究有着深厚热情的学者们共同参与。 03月26日 周日 讲座题目:Immunotherapy in Solid Tumors: New Developments 讲座嘉宾:Stefan Gluck教授 讲座时间:3月26日 10:00-10:30 讲座地点:上海细胞治疗集团多功能室(嘉定区安亭镇前杨路75号A座) 报名方式:叶博士:13661913449 Celgene 塞尔基因 Celgene(新基生物制药)创立于1980年,是一家以生物制药为主的全球企业。美国500强企业,是美国十大生物科技企业之一。 Celgene近几年将主要研发目标聚焦于肿瘤免疫治疗,已成功研发多个免疫治疗药物。 Celgene公司最近先后披露了包括CAR-T疗法在内的多个合作研发协议,这些研发协议涉及了Juno公司、BlueBird公司以及Jounce公司和阿斯利康公司。这一系列大动作让人确信Celgene公司将会在肿瘤免疫疗法领域大干一场。 Dr. Stefan Gluck MD Dr. Stefan Gluck is a medical oncologist in Summit, New Jersey and is affiliated with multiple hospitals in the area, including Jackson Memorial Hospital and University of Miami Hospital. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice for more than 20 years. He is one of 24 doctors at Jackson Memorial Hospital and one of 31 at University of Miami Hospital who specialize in Medical Oncology. He also speaks multiple languages, including German.